Overview
- The agreement announced on July 31, 2026 ended a disciplinary case that began with Mudryk's provisional suspension in December 2024 and overturned the previously imposed four-year ban.
- WADA updated the scientific criteria for detectable meldonium concentrations, and that change was central to the reassessment of Mudryk’s sample and the outcome of the appeal.
- Mudryk has denied knowingly taking a prohibited substance and accepted the infraction as part of the settlement while the period he already missed was counted as time served.
- Chelsea confirmed it will manage his return by focusing on restoring his fitness and match rhythm before full reintegration and expects him to join pre-season preparations.
- Meldonium is a metabolic drug banned by WADA in 2016 and widely used in parts of Eastern Europe, and this case shows how evolving scientific standards can overturn past anti-doping findings and affect careers.